Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

31.38 +0.15 (+0.48%)

Official Closing Price Updated: 7:00 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

48 49 Next >

Hims & Hers Health (HIMS) Surges After Hours on Robust Q3 and Renewed Novo Nordisk (NVO) Wegovy Talks

November 03, 2025

Hims & Hers Health (NYSE: HIMS) became a significant after-hours mover on Monday, November 3, 2025, following the release of its third-quarter 2025 financial results and the pivotal announcement of...

Via MarketMinute

Topics Artificial Intelligence Economy

Hims Says It's Negotiating A New Deal With Novo Nordisk; Shares Surge ↗

November 03, 2025

Hims & Hers Health said late Monday it's in discussions with Novo Nordisk to sell Wegovy shots. The news buoyed Hims stock.

Via Investor's Business Daily

Hims & Hers Stock Pops After Q3 Earnings: Here's Why ↗

November 03, 2025

Here's a look at the Q3 earnings report from Hims & Hers Health.

Via Benzinga

Hims & Hers Health’s (NYSE:HIMS) Q3 Sales Top Estimates

November 03, 2025

Telehealth company Hims & Hers Health (NYSE:HIMS) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 49.2% year on year to $599 million. On the other hand, next...

Via StockStory

Hims & Hers Q3 Preview: GLP-1 Drug Expansion Draws Investor Focus ↗

November 03, 2025

Via Stocktwits

Earnings Scheduled For November 3, 2025 ↗

November 03, 2025

Via Benzinga

Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results

November 03, 2025

From Hims & Hers

Via Business Wire

Top Stocks With Earnings This Week: Joby, IonQ, AMD and More ↗

November 03, 2025

Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday.

Via Benzinga

Stock Market Today: S&P 500, Dow Jones Futures Rise After Stellar October Gains— Micron Tech, Palantir, Hims & Hers In Focus ↗

November 03, 2025

U.S. stock futures advanced on Monday after Friday’s positive moves. Futures of major benchmark indices were higher.

Via Benzinga

Topics Stocks

Hims & Hers Health (HIMS) Q3 Earnings: What To Expect

November 01, 2025

Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting earnings this Monday afternoon. Here’s what you need to know.

Via StockStory

Why Hims & Hers Health (HIMS) Stock Is Trading Up Today

October 31, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 3.4% in the afternoon session after JPMorgan Chase & Co. disclosed in a regulatory filing that it had taken a significant passive...

Via StockStory

10 Health Care Stocks Whale Activity In Today's Session ↗

October 30, 2025

Via Benzinga

1 Profitable Stock on Our Watchlist and 2 We Find Risky

October 29, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

Topics Retirement

Hims & Hers Short Interest Nears All-Time High, Buy The Dip? ↗

October 24, 2025

Hims & Hers stock is falling well off its 52-week highs, as bears lean on the CEO's scheduled sale that just took place, though it might be a mistake.

Via MarketBeat

1 Mid-Cap Stock Worth Your Attention and 2 We Avoid

October 23, 2025

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract...

Via StockStory

Looking For The Next Beyond Meat? Here Are The Top 10 Most Shorted Stocks ↗

October 22, 2025

Here's a look at the most heavily shorted stocks in the market as investors look for the next Beyond Meat.

Via Benzinga

Short Squeeze Frenzy Fuels October's Market Rebound: A Closer Look at Bearish Bets and Bullish Surges

October 21, 2025

The U.S. stock market has staged a remarkable recovery in October 2025, with major indices reclaiming lost ground amidst a confluence of positive corporate earnings and improving macroeconomic...

Via MarketMinute

Topics Economy Stocks World Trade

This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

October 21, 2025

Via Benzinga

Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know

October 20, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 3.9% in the morning session after investors looked past a recent insider stock sale and focused on the company's strong growth...

Via StockStory

Benzinga Bulls And Bears: Stellantis, Papa John's, Oklo — And Trade Tensions Shake Chip Stocks ↗

October 18, 2025

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Via Benzinga

Topics World Trade

Trump's Weight-Loss Drug Push May Put These ETFs On A Diet ↗

October 17, 2025

Trump's vow to slash weight-loss drug prices sent Hims & Hers tumbling. These ETFs are facing new pressure.

Via Benzinga

Topics ETFs Government

Why Is Hims & Hers Health Stock Down 12% Today? ↗

October 17, 2025

According to a SEC filing on Thursday, CEO Andrew Dudum sold 175,661 shares of the company for an aggregate value of about $11 million.

Via Stocktwits

Topics Regulatory Compliance

Why Hims & Hers Health Shares Are Sliding Friday ↗

October 17, 2025

Shares of Hims & Hers Health are trading lower Friday morning after comments from President Donald Trump indicated that he expects the prices of popular weight-loss drugs to decrease.

Via Benzinga

Topics Government

Eli Lilly, Novo Nordisk, Hims & Hers Health Shares Move Lower After Trump Calls Out 'Fat-Loss Drugs' ↗

October 16, 2025

Shares of Eli Lilly and Novo Nordisk move lower in Thursday's after-hours session after President Trump indicated weight-loss drugs are going to go down in price.

Via Benzinga

Topics Government

Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today

October 16, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.8% in the afternoon session after a Bank of America analyst maintained a Sell rating on the stock, citing multiple concerns about the...

Via StockStory

Hims & Hers Stock's 150% Surge Is All Fundamentals—No Novo, No Problem ↗

October 16, 2025

Hims & Hers (HIMS) has seen surprising success, up 150% YTD, driven by their new menopause specialty and refocusing on healthcare.

Via Benzinga

Hims & Hers Stock Jumps 9% After Huge Announcement ↗

October 16, 2025

New products are coming to the Hers platform.

Via The Motley Fool

Hims & Hers Stock Notches Best Day In 3 Months After BofA’s Bullish Call On Menopause Launch: Retail Hails Year’s ‘Best Swing Trade Stock’ ↗

October 15, 2025

The rally followed BofA Securities’ announcement that the new menopause and perimenopause service represents a multi-billion-dollar market opportunity for HIMS, supporting revenue diversification.

Via Stocktwits

Hims & Hers, Salesforce, Omeros, United Airlines, And Sea Ltd: Why These 5 Stocks Are On Investors' Radars Today ↗

October 15, 2025

Major U.S. indices ended mixed on Wednesday, with the Dow Jones Industrial Average slipping 0.04% to 46,253.31.

Via Benzinga

Topics Stocks

Why Hims & Hers Stock Blasted 16% Higher on Wednesday ↗

October 15, 2025

Investors liked what they heard about the company's latest expansion of its business.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

48 49 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

All News about Hims & Hers Health, Inc. Class A Common Stock

Starting at $3.75/week.

Subscribe Today